ArticleJournal of intensive medicine2026
Global, regional, and national burdens of pancreatitis in adults aged ≥65 years from 1992 to 2021: A trends analysis using data from the 2021 Global Burden of Disease Study.
Article in Journal of intensive medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: As the global population ages, pancreatitis in older adults has become a public health issue. Nonetheless, detailed information on its global impact and changing patterns is limited. We sought to explore the epidemiological trends of pancreatitis among older adults (aged ≥65 years) from 1992 to 2021. Methods: Data for pancreatitis incidence and mortality across seven age brackets (65-69, 70-74, 75-79, 80-84, 85-89, 90-94, and ≥95 years) were sourced from the 2021 Global Burden of Diseases, Injuries, and Risk Factors Study. The age-standardized incidence and mortality rates for pancreatitis in older adults were calculated using the direct method of age standardization. Joinpoint regression analysis was used to examine the evolution of age-standardized incidence and mortality rates from 1992 to 2021. Age-period-cohort analysis was conducted to determine the distinct impacts of age, period, and birth cohorts. In addition, Nordpred analysis was applied to forecast global epidemiological trends through 2044. Results: In 2021, the estimated global age-standardized incidence and mortality rates of pancreatitis among older adults were 85.20% (95% confidence interval [CI]: 59.10 to 118.00) per 100,000 population and 7.97% (95% CI: 6.84 to 9.41) per 100,000 population, respectively. The disease burden of incidence and mortality was greatest in Eastern Europe. From 1992 to 2021, both the estimated global age-standardized incidence and mortality rates of pancreatitis among older adults demonstrated significant declining trends. The evolution of trends varied significantly across different regions and 204 countries, with an increased trend of age-standardized incidence rates in the Sociodemographic Index (SDI) regions. The age-period-cohort analysis results showed that the relative risk of incidence and mortality generally exhibited unfavorable trends over time in low-middle and low SDI regions. In addition, the age-standardized incidence and mortality rates were predicted to decrease annually, whereas case numbers of these metrics were predicted to keep increasing until 2044. Conclusions: There are strong heterogeneities in the incidence and mortality trends of older pancreatitis across the world, including both growing case numbers and distributive disparities, which may be instructive for future explorations in the prevention and treatment of this disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.